Yan-yan Zhan

school of medicine

H指数:23

被引数:1,962

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

AIF promotes ovarian cancer progression by competitively binding TRAP1 to stabilize MtCK1 to drive phosphocreatine synthesis

AIF通过竞争性结合TRAP1稳定MtCK1以驱动磷酸肌酸合成促进卵巢癌进展

Journal of Translational Medicine

IF7.5

2026-08-170

FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3-Mediated ErbB3 Fucosylation in Lung Adenocarcinoma

FUCA2通过拮抗FUT3介导的ErbB3岩藻糖基化来维持AKT信号通路并抑制肺腺癌衰老

Advanced Science

IF14.1

2026-06-160

OAAI

YTHDC1 drives senescence evasion in ovarian cancer through m6A-mediated TERT stabilization

YTHDC1通过m6A介导的TERT稳定化驱动卵巢癌的衰老逃逸

Cell Death & Disease

IF9.6

2026-05-300

OAAI

HNF4α-HKDC1 axis orchestrates a metabolic rewiring to promote migration and metastasis in advanced gastric cancer

HNF4α-HKDC1轴调控代谢重编程以促进晚期胃癌的迁移和转移。

Cell Death & Disease

IF9.6

2026-03-230

OAAI

Identification of a novel prognostic marker ADGRG6 in pancreatic adenocarcinoma: multi-omics analysis and experimental validation

鉴定胰腺腺癌中一个新的预后标志物ADGRG6：多组学分析和实验验证

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-03-270

TGM1/3-mediated transamidation of Exo70 promotes tumor metastasis upon LKB1 inactivation

CELL REPORTS

IF6.9

2024-08-011

OAAI

Early detection of uterine corpus endometrial carcinoma utilizing plasma cfDNA fragmentomics

BMC MEDICINE

IF8.3

2024-07-291

OAAI

Berplatin: A Conjugate of Berberine and Cisplatin Serving as a Potent Antitumor Agent with Distinctive Tumor Cell Uptake and Minimal Side Effects

ADVANCED THERAPEUTICS

IF2.6

2022-12-090

PRE

Gap junctions mediate glucose transfer to promote colon cancer growth in three-dimensional spheroid culture

CANCER LETTERS

IF10.1

2022-04-017

The HNF4α-BC200-FMR1-Positive Feedback Loop Promotes Growth and Metastasis in Invasive Mucinous

CANCER RESEARCH

IF16.6

2021-12-0115

Loss of the common immune coreceptor BAK1 leads to NLR-dependent cell death

共同免疫共同受体BAK1的丧失导致NLR依赖性细胞死亡

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2020-10-1464

OAAI

Structure-Activity Relationship Study Enables the Discovery of a Novel Berberine Analogue as the RXRα Activator to Inhibit Colon Cancer

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2020-05-1126

PREAI

ULK1 phosphorylates Exo70 to suppress breast cancer metastasis

NATURE COMMUNICATIONS

IF15.7

2020-01-0839

OAAI

Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ-based quantitative proteomics analysis

ONCOLOGY REPORTS

IF3.9

2019-10-2321

OAAI

Identification of Chaetocin as a Potent non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer

JOURNAL OF CANCER

IF3.2

2019-01-0115

OAAI

High expression of Tob1 indicates poor survival outcome and promotes tumour progression via a Wnt positive feedback loop in colon cancer

MOLECULAR CANCER

IF33.9

2018-11-1714

OAAI

Berberine decelerates glucose metabolism via suppression of mTOR-dependent HIF-1α protein synthesis in colon cancer cells

ONCOLOGY REPORTS

IF3.9

2018-03-1663

OAAI

Berberine inhibits colitis-associated tumorigenesis via suppressing inflammatory responses and the consequent EGFR signaling-involved tumor cell growth

LABORATORY INVESTIGATION

IF4.2

2017-11-0160

OAAI

Phosphoinositide-specific phospholipase Cγ1 inhibition induces autophagy in human colon cancer and hepatocellular carcinoma cells

SCIENTIFIC REPORTS

IF3.9

2017-10-2420

OAAI

Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells

ONCOGENE

IF7.3

2017-08-28121

OAAI

Yan-yan Zhan

个人简介

教育背景

工作经历

荣誉奖项

研究方向